Prescribing Information

Full Prescribing Information
The full Prescribing Information for Visudyne^® includes a detailed list of ingredients as well as information on possible side effects, drug interactions, and precautions. It is provided in Portable Document Format (PDF). To view and print this document, you need a copy of the free Adobe Reader. If you already have Adobe Reader installed, click "View full Prescribing Information."

If you need Adobe Reader, click here to download the free reader.

View full Prescribing Information

Visudyne is a treatment to help slow the loss of vision in persons with predominantly classic wet AMD.

Important Safety Information

Visudyne therapy is not for everyone. People who have an abnormal sensitivity to light (a condition called porphyria) and those with allergies to any of the ingredients should not receive Visudyne. (Your doctor has a list of ingredients in Visudyne.) Check with your doctor or healthcare professional to see if you might be allergic to any component of Visudyne therapy. Only your doctor can determine if Visudyne is right for you.

Changes in vision, including blurring, decreased sharpness in vision, and gaps in vision are some of the most commonly reported side effects. Between 1% and 5% of patients experienced a substantial decrease in vision in the first 7 days after treatment, though some patients achieved partial recovery. Patients who experience substantial vision loss should consult their healthcare professional immediately. Injection site reactions and temporary back pain during injection were some of the most commonly reported side effects.

Patients should avoid direct sunlight or bright indoor light for 5 days following therapy with Visudyne.

Patients who have to go outdoors in daylight after treatment must protect all parts of their skin and eyes by wearing protective clothing and dark glasses. Ultraviolet (UV) sunscreens are not effective in protecting against photosensitivity reactions.

Please see full Prescribing Information.